Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Jun 6;19(6):e0301611. doi: 10.1371/journal.pone.0301611

Molecular identification of Coxiella burnetii in raw milk samples collected from farm animals in districts Kasur and Lahore of Punjab, Pakistan

Shahpal Shujat 1,2, Wasim Shehzad 1, Aftab Ahmad Anjum 3, Julia A Hertl 2, Yrjö T Gröhn 2, Muhammad Yasir Zahoor 1,*
Editor: Gianmarco Ferrara4
PMCID: PMC11156400  PMID: 38843180

Abstract

Coxiella burnetii is the worldwide zoonotic infectious agent for Q fever in humans and animals. Farm animals are the main reservoirs of C. burnetii infection, which is mainly transmitted via tick bites. In humans, oral, percutaneous, and respiratory routes are the primary sources of infection transmission. The clinical signs vary from flu-like symptoms to endocarditis for humans’ acute and chronic Q fever. While it is usually asymptomatic in livestock, abortion, stillbirth, infertility, mastitis, and endometritis are its clinical consequences. Infected farm animals shed C. burnetii in birth products, milk, feces, vaginal mucus, and urine. Milk is an important source of infection among foods of animal origin. This study aimed to determine the prevalence and molecular characterization of C. burnetii in milk samples of dairy animals from two districts in Punjab, Pakistan, as it has not been reported there so far. Using a convenience sampling approach, the current study included 304 individual milk samples from different herds of cattle, buffalo, goats, and sheep present on 39 farms in 11 villages in the districts of Kasur and Lahore. PCR targeting the IS1111 gene sequence was used for its detection. Coxiella burnetii DNA was present in 19 of the 304 (6.3%) samples. The distribution was 7.2% and 5.2% in districts Kasur and Lahore, respectively. The results showed the distribution in ruminants as 3.4% in buffalo, 5.6% in cattle, 6.7% in goats, and 10.6% in sheep. From the univariable analysis, the clinical signs of infection i.e. mastitis and abortion were analyzed for the prevalence of Coxiella burnetii. The obtained sequences were identical to the previously reported sequence of a local strain in district Lahore, Sahiwal and Attock. These findings demonstrated that the prevalence of C. burnetii in raw milk samples deserves more attention from the health care system and veterinary organizations in Kasur and Lahore of Punjab, Pakistan. Future studies should include different districts and human populations, especially professionals working with animals, to estimate the prevalence of C. burnetii.

Introduction

Coxiella burnetii is a gram-negative obligate intracellular bacterium. It is an etiological agent of Q fever in humans and animals [1]. The Center for Disease Control and Prevention has classified it as a category B bioweapon due to its aerosolized property and rapid spread. This bacterium can cause disease in a low infectious dose; only 1–10 organisms are required for this infection [24]. Its spore-like structure can persist under harsh environmental conditions and stress [5].

Coxiella burnetii has been globally ranked among the top 13 priority zoonotic pathogens. It can infect different host species, including domestic, wild, and marine mammals, birds, reptiles, and arthropods. Ruminants are the main reservoirs for this pathogen [6]. It is a tick-borne pathogen; thus, it is transmitted to ruminants mainly through ticks [7]. In humans, infection may occur through inhalation of particles dispersed from environmental dust [8] and direct contact with contaminated milk, meat, urine, semen, and feces [9]. Clinical manifestation of this bacterium in ruminants includes stillbirth, abortion, mastitis, endometritis, and other reproductive disorders [10,11]. In humans, flu, fever, hepatitis, and endocarditis are the main manifestations [12].

The pathogen was first identified in Australian abattoir workers [13]. It has been considered endemic and has a worldwide distribution including Pakistan. It has gained international attention since the outbreak in the Netherlands from 2007 to 2010, and has affected humans and farm animals in other European countries [11]. Most cases remain undiagnosed due to a lack of proper diagnostic tools in developing countries like Pakistan.

It has been detected using serological and molecular tests from numerous samples, i.e., blood, serum, milk, and meat. Culturing techniques for C. burnetii detection are rarely used because of its high pathogenicity. PCR is the most sensitive molecular technique for the detection of C. burnetii. Single copy and multicopy gene targets are used for its detection. The superoxide dismutase gene and IS1111 gene are single and multicopy gene targets [14].

Raw milk from livestock animals is a potential source of C. burnetii infection. In the USA, there was a report of infection by C. burnetii by consumption of raw milk from a dairy in Michigan [15] and a further study reported C. burnetii infection in Colombian farmers [16]. Although seroconversion is frequently the result of consuming raw milk or dairy products, clinical Q fever is rarely a consequence [17]. Food has been considered a “seldom recorded route” for the transmission of C. burnetii; at this point, food consumption cannot be eliminated from the assessment of Q fever transmission channels, and a One Health approach must extend to consideration of this potential. Simulation studies conducted by Gale et al. [18], together with a comprehensive literature review in 2018 by Pexara et al. [19] led the latter authors to conclude that the risk of C. burnetii human infection due to consumption of unpasteurized milk and raw milk products “cannot be considered negligible” [18,19].

The bacterium has been known to shed via the milk of cattle in several European countries; in Poland, for example, it was found in 31.54% of tested dairy cattle herds’ milk [20]. In Latvia, a survey of dairy cattle operations revealed that 10.7% of bulk tank milk samples tested positive for the presence of C. burnetii DNA [21].

Several countries have tested dairy products other than milk for the presence of C. burnetii DNA. It was discovered that 69.2% of the dairy products in Poland tested positive [20]. In Spain, 7.6% of hard cheeses made from raw sheep’s milk included pathogenic bacteria, and 29.9% of them had C. burnetii DNA [22].

Coxiella burnetii is a neglected pathogen in Pakistan, although it strongly impacts an infected country’s economy and public health. Appropriate farm management and public awareness are required to control this infection. Moreover, the infection remains largely undetected mainly due to limited diagnostic facilities and the lack of sufficient training to healthcare workers and clinical physicians for this contagious disease in developing countries like Pakistan. Notably, in the previous 65 years, there have been only six publications on human and animal Q fever from Pakistan in the PubMed databank [2329]. Information regarding C. burnetii’s manifestation in milk obtained from small and large ruminants for human consumption has not been assessed so far in Pakistan, although there are reports from other countries in Asia including India and China. The objective of the current study was to estimate the prevalence and molecular characterization of C. burnetii in milk samples collected from ruminants used for human consumption.

Methodology

Study area and sampling

The sampling was conducted in 2019 with the help of the livestock department of Districts Kasur and Lahore. The samples were collected from the consent of dairy farmers using a convenience approach (Fig 1). The study included 304 individual milk samples of 90 cattle, 88 buffalo, 60 goat, and 66 sheep collected from 39 farms in 11 Kasur and Lahore villages. Milk samples of about 5 ml were collected in 15 ml sterile falcon tubes, and the information was recorded in the sample collection data book. The collected samples were transported at 4 to 8°C temperature.

Fig 1. A map showing the sampling locations in the study area of districts Kasur and Lahore, Punjab.

Fig 1

The map was created using GADM R-package, developed by [30].

Inclusion and exclusion criteria

The local commercial and household farms were selected in the current study while institutional farms were excluded from the study. Animals that were treated with antibiotics or diagnosed with other diseases were excluded from the study.

Milk processing and DNA isolation

Milk samples were stored at -20°C and further processed for DNA extraction using a manual method. Milk samples of 200 μl were placed in a microcentrifuge tube and centrifuged at 14500 rpm for 15 min at 4°C, and the cream layer was separated [31]. Lysis buffer of 700 μl and 10 μl of proteinase K were taken in its pellet and incubated at 56°C overnight. After overnight incubation, 500 μl of PCI was added and vortexed until the solution turned milky. Then it was centrifuged under identical conditions as mentioned above. Three layers were formed, and the upper transparent layer containing DNA was taken into a separate microcentrifuge tube. Two parts of isopropanol and 200 μl of chilled absolute ethanol were added in 1 part aqueous transparent layer and incubated for 20 min at -20°C. It was then centrifuged under the same conditions, the supernatant was discarded, and the pellet was taken. The taken pellet was washed using 200 μl of 70% ethanol and centrifuged under the same conditions. Then the supernatant was discarded, leaving the pellet drying overnight to evaporate ethanol, and acting as a PCR inhibitor. The dried pellet was dissolved in 20 μl of distilled water in a water bath and heat shocked at 70°C for 40 minutes. DNA quality and quantity were assessed using a spectrophotometer.

Molecular assay and sequence analysis

Coxiella burnetii was diagnosed using multiple copy gene amplification assays targeting transposase gene, i.e., IS1111; specific primers were used for this assay. The set of primers used for the PCR amplification assay was sequenced as 5’-GTCTTAAGGTGGGCTGCGTG-3’and 5’-CCCCGAATCTCATTGATCAGC-3’ for forward and reverse primer [32]. The assay was sensitive due to its multiple copy gene targets and specificity was confirmed by alignment with the reported sequences of C. burnetii and results were validated using alignment of the obtained sequences for positive samples. The diagnostic assay was validated using Vircell Amplirun® Coxiella DNA Control. Each PCR reaction test contained 12.5 μl of 2X master mix, 1.25 μl of 10μM forward and reverse primer, and 1 μl of 50–100 ng DNA in a final volume up to 25 μl by adding nuclease-free water. PCR reaction was performed using a 96 well Applied Biosystems by Thermo Fisher Scientific thermal cycler. The conditions for reaction were optimized as initial denaturation at 95°C for 5 min, final denaturation at 94°C for 30 sec, annealing at 60°C for 30 sec, extension at 72°C for 1 min, repeat steps 1 to 3 for 30 cycles, and final extension at 72°C for 10 min. PCR products were analyzed on 2% agarose gel, and specific product was identified, i.e., 294 bp was observed during analysis. The positive samples were sequenced from commercially available services. The sequences were analyzed for phylogenetics using the MEGA version 6.0 bioinformatics tool. Alignment and phylogenetic tree construction of 12 sequences, including two query sequences, were performed using the MEGA tool by the maximum likelihood method [33].

Data analysis

The data were recorded in a Microsoft Excel spreadsheet. The analysis was performed using SAS 9.4 statistical package (see S1 File). Fisher exact tests were performed using the fisher.test function in R 4.3.2, and logistic regression models were fitted using PROC LOGISTIC in SAS 9.4 with the presence/absence of C. burnetii DNA as the outcome variable. The explanatory variables in the study included species, district and abortion.

Ethics statement

The University of Veterinary and Animal Sciences’ Advanced Studies and Research Board granted ethics approval to undertake the study in its 50th meeting held on 8 February 2019. The raw milk samples and information collected from the individual animals was collected with the informed consent of dairy farmers. The raw milk samples were collected with the assistance of animal handlers.

Results

Of 304 samples, 19 (6.3%) were positive for C. burnetii DNA by PCR detection using the IS1111 sequence. The observed results showed a higher prevalence of C. burnetii in district Kasur (7.1%) when compared with district Lahore (5.1%) (Table 1), although it was not statistically significant (P = 0.63). Coxiella burnetii prevalence in the four species of ruminants was 3.4% in buffalo, 5.6% in cattle, 6.7% in goats, and 10.6% in sheep (Table 1). Thus, the prevalence of C. burnetii was higher in milk samples obtained from goats and sheep than in cattle and buffalo, although the differences between districts for each species were not statistically different (Table 2). From a logistic regression model with district, species, and an interaction between district and species, in Lahore, sheep were 13 times (95% confidence limits: 1.36, 126.02) more likely to test positive than were buffalo, and were 10.4 times (95% confidence limits: 1.07, 100.0) more likely to test positive than were cattle. No significant association was detected between abortion and infection status for any of the species (Table 3).

Table 1. Prevalence of Coxiella burnetii in milk samples collected from different species by PCR during 2019, from districts Lahore and Kasur, Pakistan.

No. of samples examined No. of positive samples Percentage
Species
Cattle 90 5 5.6
Buffalo 88 3 3.4
Goat 60 4 6.7
Sheep 66 7 10.6
District
Lahore 136 7 5.2
Kasur 168 12 7.2
Total 304 19 6.3

Table 2. Prevalence of Coxiella burnetii in milk samples collected during 2019 from different species and its distribution in districts Lahore and Kasur, Pakistan.

Species District Lahore District Kasur Overall P value
Cattle 2.5% (1/40) 8% (4/50) 5.6% (5/90) 0.30
Buffalo 2% (1/50) 5.3% (2/38) 3.4% (3/88) 0.37
Goat 3.7% (1/27) 9.1% (3/33) 6.7% (4/60) 0.39
Sheep 21.1% (4/19) 6.4% (3/47) 10.6% (7/66) 0.34

Table 3. Prevalence of Coxiella burnetii in milk samples collected from different species when the clinical sign, abortion was analyzed using univariate analysis.

Abortion Infection Cattle Buffalo Goat Sheep Overall
Frequency Frequency Frequency Frequency Frequency
Yes Positive 1 (33%) 0 0 0 1
Negative 2 (67%) 0 2 0 4
Total 3 0 2 0 5
No Positive 4 (5%) 3 (3%) 4 7 18 (6%)
Negative 83 (95%) 85 (97%) 54 59 281 (94%)
Total 87 88 58 66 299
P value 0.16 - - - 0.28

When the sequences were aligned on the basis of their origin, the results showed that in the current study, the sequences obtained from district Lahore were clustered with previously reported sequences from districts Lahore and Sahiwal because of their close geographical proximity. At the same time, the sequences obtained from district Kasur were clustered separately with previously reported sequences from district Attock (Fig 2).

Fig 2. The phylogenetic relationship of C.burnetii IS1111 gene sequence recovered from milk samples in 2019 in districts Lahore and Kasur.

Fig 2

Query sequences are labeled in the figure.

Discussion

The aims of the present study were to estimate the prevalence and undertake a molecular characterization of C. burnetii DNA in raw milk samples collected from different herds of ruminants in the districts of Lahore and Kasur, Pakistan. The first evidence of C. burnetii DNA in milk was obtained during this study in Pakistan. Previous studies evaluated the pathogen’s presence in meat, ticks, blood, and serum samples collected from ruminants, environmental samples (i.e., soil samples obtained from animal farms), and human blood samples [2228]. Coxiella burnetii in raw milk from ruminants was not studied previously. The absence of previous records was due to a lack of awareness and neglect of the disease caused by this pathogen.

There is variation in the clinical manifestations of C. burnetii in humans. In general, it may be asymptomatic or may show signs of acute or chronic manifestation [34]. People with acute C. burnetii infection typically experience mild or asymptomatic flu-like symptoms [1]. Most of the time, only a small percentage of infected individuals exhibit an actual disease, which can lead to serious complications [11]. The disease may cause a chronic infection in certain infected cases, which could have long-term sequelae. C. burnetii was thought to be primarily an occupational hazard, and human infection may be strongly related to direct contact with ruminants [16]. Furthermore, an assessment of the zoonotic pathogen presence within foods of animal origin and the potential threat to public health is required considering the high prevalence of C. burnetii in production animals. When it pertains to foods of animal origin, raw milk is the most important source of Coxiella burnetii infection, through raw milk or raw milk products [17]. The current study was based on a one health approach and this zoonotic pathogen was recovered from milk samples used for human consumption. The estimated overall prevalence of C. burnetii was 6.25%, while it was 7.14% in district Kasur and 5.15% in district Lahore. Previous studies suggested a 36.87% C. burnetii prevalence in blood samples of small ruminants from district Kasur while the prevalence of C. burnetii was estimated at 32.1% and 12.5% in cattle and buffaloes, respectively [35]. For district Lahore, the prevalence of infection was 4.8% in environmental samples from a previously reported study [28].

Based on the results of this study, C. burnetii was detected in 6.7% of goat milk samples by PCR using the IS1111 gene sequence. The prevalence of C. burnetii in districts Lahore and Kasur was 2% and 9%, respectively. A previous study estimated the prevalence of infection in goat blood samples as 30% in district Kasur [35]. The reported prevalence of infection in other countries was 6.3–12.1% in Belgium [36], 14.3% in the USA [37], and 17.2% in Lebanon [38]. Goat’s milk is frequently consumed in various countries throughout the world. Therefore, goat milk used for human consumption should be screened for C. burnetii, among other pathogens.

The results showed that 10.6% of sheep milk samples were positive for the causative agent of Q fever. The estimated prevalence in the two districts was 21.1% and 6.4% in Lahore and Kasur, respectively. In another recent study, C. burnetii prevalence was reported as 46.9% in the Kasur district [39]. The prevalence of C. burnetii in other countries was 10% in Lebanon [38], 4% in Hungary [40], 6.5% in Turkey [41], and 22% in Spain [42]. According to the findings of this study and previous studies in Pakistan and other countries, it seems that C. burnetii is common in sheep. Like goat milk, there is a strong interest in consuming raw sheep’s milk and its products in Pakistan, especially in rural and nomadic populations that consume milk from these species. Therefore, paying attention to milk-borne pathogens in such communities is essential, and veterinary organizations must prioritize control and prevention strategies in livestock.

The current study estimated C. burnetii prevalence in cattle as 5.6%; the prevalence was 2.5% in Lahore district and 8% in Kasur district. The prevalence of C. burnetii in buffaloes was 3.4%. The distribution of C. burnetii prevalence in buffaloes in Lahore and Kasur was estimated at 2% and 5.3%, respectively. A previous study showed 32.12% and 12.5% in cattle and buffaloes for the prevalence of C. burnetii in district Kasur [39]. Different prevalences of C. burnetii have been reported in cattle milk from other countries: 8.7% in Hungary [40], 15.1% in Lebanon [38], 18.8% in the Netherlands [43] and 27% in Italy [44]. Therefore, shedding of pathogens in milk by bovines appears to be the most critical route of spreading this bacterium in the environment in all investigated countries. Future studies should include other districts of Punjab, Pakistan, and sectors of the human population at risk, especially professionals, i.e., farm workers and veterinarians. Given that some countries have reported pediatric cases of alimentary infection with C. burnetii and that dairy products are a staple of the diet starting at six months of age, special attention was given to yoghurts and other fermented products with added ingredients that are frequently consumed by both adults and children [45,46]. In this study, molecular evidence of C. burnetii was detected in milk samples of dairy animals in the districts of Kasur and Lahore. These findings demonstrated that C. burnetii prevalence, especially in raw milk samples, could pose a severe risk of Q fever to farm workers and consumers in Punjab, Pakistan.

One limitation of the current study is the relatively small number of cases detected, and this limited the statistical power to detect associations such as differences in prevalence between species and between districts. This could be addressed by further monitoring of milk samples, not only from these two districts, but in other districts and across the provinces of Pakistan. In addition, further molecular characterization and identification of other gene targets to identify strains would be helpful in the context of Pakistani dairy animals. Nevertheless, it is considered an important finding about Coxiella infection of milk products in Pakistan, and it is recommended that the dairy industry should implement screening of dairy items manufactured from raw milk such as cream, desserts, yoghurt, butter and cheese to address this public health issue.

Conclusion

Molecular evidence of C. burnetii was observed in milk samples of cattle, buffalo, goats, and sheep collected from the farm in two districts of Punjab, Pakistan. These findings emphasized that the prevalence of C. burnetii, especially in raw milk samples, deserves more attention from the public health system and dairy industry in Pakistan. The stakeholders in the dairy sector should be attentive for diagnosis and vaccination of dairy animals for C. burnetii infection. The infection causes abortion, mastitis and other reproductive issues in dairy animals, and the milk from the animals with mastitis cannot be sold. The abortion and other reproductive issues in dairy animal due to C.burnetii infection are important in economic and health aspects. Furthermore, dairy products should market the pasteurized milk and milk products to ensure adequate consumer health protection. Future studies must include other districts and risk evaluation in the human population for the infection, especially in professionals, i.e., farm workers, dairy processing industry workers and veterinarians.

Supporting information

S1 File. Supplementary tables.

(PDF)

pone.0301611.s001.pdf (198.1KB, pdf)
S2 File

(MAS)

pone.0301611.s002.mas (118.6KB, mas)
S3 File

(SAS7BDAT)

pone.0301611.s003.sas7bdat (128KB, sas7bdat)
S4 File

(TXT)

pone.0301611.s004.txt (13.8KB, txt)

Acknowledgments

The authors are grateful to Assistant Director Livestock District Kasur Dr. Musarat, Veterinary Assistants in Livestock Department District Kasur, farmers and Assistant Director Livestock, District Lahore, and Veterinary Assistants Livestock Department, District Lahore for assisting in sample collection and data recording.

Data Availability

All relevant data for this study are publicly available from the OSF repository (https://osf.io/hzd9c).

Funding Statement

Funding Statement This study was funded by International Research Support Initiative Program, Higher Education Comission, Pakistan fellowship. Grant: I -8/HEC/HRD/2021/11529 awarded to student. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.

References

  • 1.Maurin M, Raoult Df. Q fever. Clinical microbiology reviews. 1999;12(4):518–53. doi: 10.1128/CMR.12.4.518 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Benenson A, Tigertt W. Studies on Q fever in man. Transactions of the Association of American Physicians. 1956;69(1):98. [PubMed] [Google Scholar]
  • 3.Gonder JC, Kishimoto RA, Kastello MD, Pedersen CE Jr, Larson EW. Cynomolgus monkey model for experimental Q fever infection. Journal of Infectious Diseases. 1979;139(2):191–6. doi: 10.1093/infdis/139.2.191 [DOI] [PubMed] [Google Scholar]
  • 4.Marrie TJ, Langille D, Papukna V, Yates L. Truckin’pneumonia—an outbreak of Q fever in a truck repair plant probably due to aerosols from clothing contaminated by contact with newborn kittens. Epidemiology & Infection. 1989;102(1):119–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kersh GJ, Fitzpatrick KA, Self JS, Priestley RA, Kelly AJ, Lash RR, et al. Presence and persistence of Coxiella burnetii in the environments of goat farms associated with a Q fever outbreak. Applied and environmental microbiology. 2013;79(5):1697–703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Eldin C, Melenotte C, Mediannikov O, Ghigo E, Million M, Edouard S, et al. From Q fever to Coxiella burnetii infection: a paradigm change. Clinical microbiology reviews. 2017;30(1):115–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Stoker M, Marmion B. The spread of Q fever from animals to man: the natural history of a rickettsial disease. Bulletin of the World Health Organization. 1955;13(5):781. [PMC free article] [PubMed] [Google Scholar]
  • 8.Marrero M, Raoult D. Centrifugation-shell vial technique for rapid detection of Mediterranean spotted fever rickettsia in blood culture. The American journal of tropical medicine and hygiene. 1989;40(2):197–9. doi: 10.4269/ajtmh.1989.40.197 [DOI] [PubMed] [Google Scholar]
  • 9.Johnson JE, Kadull PJ. Laboratory-acquired Q fever: a report of fifty cases. The American journal of medicine. 1966;41(3):391–403. [DOI] [PubMed] [Google Scholar]
  • 10.Marrie TJ. 20 Epidemiology of Q Fever. Rickettsial diseases. 2007:281. [Google Scholar]
  • 11.Arricau-Bouvery N, Rodolakis A. Is Q fever an emerging or re-emerging zoonosis? Veterinary research. 2005;36(3):327–49. doi: 10.1051/vetres:2005010 [DOI] [PubMed] [Google Scholar]
  • 12.Marrie TJ, Stein A, Janigan D, Raoult D. Route of infection determines the clinical manifestations of acute Q fever. Journal of Infectious Diseases. 1996;173(2):484–7. doi: 10.1093/infdis/173.2.484 [DOI] [PubMed] [Google Scholar]
  • 13.Derrick E. "Q" Fever, a New Fever Entity: Clinical Features, Diagnosis and Laboratory Investigation. Medical Journal of Australia. 1937;2(8); 790–800. [DOI] [PubMed] [Google Scholar]
  • 14.Fenollar F, Raoult D. Molecular genetic methods for the diagnosis of fastidious microorganisms. Apmis. 2004;112(11‐12):785–807. doi: 10.1111/j.1600-0463.2004.apm11211-1206.x [DOI] [PubMed] [Google Scholar]
  • 15.Signs KA, Stobierski MG, Gandhi TN. Q fever cluster among raw milk drinkers in Michigan. Clinical Infectious Diseases. 2012;55(10):1387–1389. [DOI] [PubMed] [Google Scholar]
  • 16.Cabrera Orrego R, Ríos-Osorio LA, Keynan Y, Rueda ZV, Gutiérrez LA. Molecular detection of Coxiella burnetii in livestock farmers and cattle from Magdalena Medio in Antioquia, Colombia. PLoS One. 2020;15(6):e0234360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Cerf O, Condron R. Coxiella burnetii and milk pasteurization: an early application of the precautionary principle? Epidemiology & Infection. 2006;134(5):946–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gale P, Kelly L, Mearns R, Duggan J, Snary EL. Q fever through consumption of unpasteurised milk and milk products–a risk profile and exposure assessment. Journal of applied microbiology. 2015;118(5):1083–95. doi: 10.1111/jam.12778 [DOI] [PubMed] [Google Scholar]
  • 19.Pexara A, Solomakos N, Govaris A. Q fever and prevalence of Coxiella burnetii in milk. Trends in Food Science & Technology. 2018;71(5):65–72. [Google Scholar]
  • 20.Szymańska-Czerwińska M, Jodełko A, Zaręba-Marchewka K, Niemczuk K. Shedding and genetic diversity of Coxiella burnetii in Polish dairy cattle. PLoS One. 2019;14(1): e0210244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Boroduske A, Trofimova J, Kibilds J, Papule U, Sergejeva M, Rodze I, et al. Coxiella burnetii (Q fever) infection in dairy cattle and associated risk factors in Latvia. Epidemiology & Infection. 2017;145(10):2011–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Barandika JF, Alvarez-Alonso R, Jado I, Hurtado A, García-Pérez AL. Viable Coxiella burnetii in hard cheeses made with unpasteurized milk. International Journal of Food Microbiology. 2019;303:42–5. [DOI] [PubMed] [Google Scholar]
  • 23.Shujat S, Shehzad W, Anjum AA, Hertl JA, Zahoor MY, Gröhn YT. Molecular detection of Coxiella burnetii in raw meat samples collected from different abattoirs in districts Kasur and Lahore of Punjab, Pakistan. PLoS One. 2023;18(8): e0289944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ullah Q, Jamil H, Qureshi ZI, Saqib M, Neubauer H. Sero-Epidemiology of Q Fever (Coxiellosis) in Small Ruminants Kept at Government Livestock Farms of Punjab, Pakistan. Pakistan Journal of Zoology. 2019;51(1). [Google Scholar]
  • 25.Ahmed IP. A serological investigation of Q fever in Pakistan. J Pak Med Assoc. 1987;37:126–9. [PubMed] [Google Scholar]
  • 26.Ayaz M, Bari A, Humayun A, editors. Coxiellosis in man and animals in northern parts of Pakistan. Proceedings of Pakistan Congress of Zoology; 1993.
  • 27.Kaplan MM, Bertagna P. The geographical distribution of Q fever. Bulletin of the World Health Organization. 1955;13(5):829. [PMC free article] [PubMed] [Google Scholar]
  • 28.Shabbir MZ, Akram S, ul Hassan Z, Hanif K, Rabbani M, Muhammad J, et al. Evidence of Coxiella burnetii in Punjab province, Pakistan. Acta tropica. 2016;163:61–9. [DOI] [PubMed] [Google Scholar]
  • 29.Zahid MU, Hussain MH, Saqib M, Neubauer H, Abbas G, Khan I, et al. Seroprevalence of Q fever (Coxiellosis) in small ruminants of two districts in Punjab, Pakistan. Vector-Borne and Zoonotic Diseases. 2016;16(7):449–54. doi: 10.1089/vbz.2015.1852 [DOI] [PubMed] [Google Scholar]
  • 30.Brinks J, Milán M. GADM: Database of Global Administrative Boundries. R package version 4.0.3.2020; https://gadm.org/download_country_v3.html.
  • 31.Berri M, Laroucau K, Rodolakis A. The detection of Coxiella burnetii from ovine genital swabs, milk and fecal samples by the use of a single touchdown polymerase chain reaction. Veterinary microbiology. 2000;72(3–4):285–93. [DOI] [PubMed] [Google Scholar]
  • 32.Tozer S, Lambert S, Strong C, Field H, Sloots T, Nissen M. Potential Animal and Environmental Sources of Q Fever Infection for Humans in Queensland. Zoonoses and public health. 2014;61(2):105–12. doi: 10.1111/zph.12051 [DOI] [PubMed] [Google Scholar]
  • 33.Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Molecular biology and evolution. 2013;30(12):2725–9. doi: 10.1093/molbev/mst197 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Angelakis E, Raoult D. Q fever. Veterinary microbiology. 2010;140(3–4):297–309. doi: 10.1016/j.vetmic.2009.07.016 [DOI] [PubMed] [Google Scholar]
  • 35.Iqbal MZ, Durrani AZ, Khan JA, Ahmad N, Usman M, Jabbar A, et al. Molecular epidemiology of Coxiella burnetii in small ruminants in Punjab, Pakistan: a novel reporting analytical cross sectional study. Tropical Animal Health and Production. 2021;53(1):1–8. [DOI] [PubMed] [Google Scholar]
  • 36.Boarbi S, Mori M, Rousset E, Sidi-Boumedine K, Van Esbroeck M, Fretin D. Prevalence and molecular typing of Coxiella burnetii in bulk tank milk in Belgian dairy goats, 2009–2013. Veterinary microbiology. 2014;170(1–2):117–24. [DOI] [PubMed] [Google Scholar]
  • 37.Loftis AD, Priestley RA, Massung RF. Detection of Coxiella burnetii in commercially available raw milk from the United States. Foodborne pathogens and disease. 2010;7(12):1453–6. [DOI] [PubMed] [Google Scholar]
  • 38.Dabaja M, Greco G, Villari S, Vesco G, Bayan A, El Bazzal B, et al. Occurrence and risk factors of Coxiella burnetii in domestic ruminants in Lebanon. Comparative immunology, microbiology and infectious diseases. 2019;64:109–16. [DOI] [PubMed] [Google Scholar]
  • 39.Iqbal MZ, Durrani AZ, Khan JA, Ahmad N, Usman M, Jabbar A, et al. Molecular Identification of Coxiella burnetii, and Incidence and Risk Factors of Coxiellosis in Bovines of Punjab, Pakistan. Pakistan Journal of Zoology. 2022;54(4);1859–1867. [Google Scholar]
  • 40.Gyuranecz M, Dénes B, Hornok S, Kovács P, Horváth G, Jurkovich V, et al. Prevalence of Coxiella burnetii in Hungary: screening of dairy cows, sheep, commercial milk samples, and ticks. Vector-Borne and Zoonotic Diseases. 2012;12(8):650–3. [DOI] [PubMed] [Google Scholar]
  • 41.Öngör H, Cetinkaya B, Karahan M, Acik MN, Bulut H, Muz A. Detection of Coxiella burnetii by immunomagnetic separation-PCR in the milk of sheep in Turkey. Veterinary record. 2004;154(18):570–2. [DOI] [PubMed] [Google Scholar]
  • 42.García-Pérez A, Astobiza I, Barandika J, Atxaerandio R, Hurtado A, Juste R. Investigation of Coxiella burnetii occurrence in dairy sheep flocks by bulk-tank milk analysis and antibody level determination. Journal of dairy science. 2009;92(4):1581–4. [DOI] [PubMed] [Google Scholar]
  • 43.Van Engelen E, Schotten N, Schimmer B, Hautvast J, Van Schaik G, Van Duijnhoven Y. Prevalence and risk factors for Coxiella burnetii (Q fever) in Dutch dairy cattle herds based on bulk tank milk testing. Preventive Veterinary Medicine. 2014;117(1):103–9. [DOI] [PubMed] [Google Scholar]
  • 44.Petruzzelli A, Amagliani G, Micci E, Foglini M, Di Renzo E, Brandi G, et al. Prevalence assessment of Coxiella burnetii and verocytotoxin-producing Escherichia coli in bovine raw milk through molecular identification. Food control. 2013;32(2):532–6. [Google Scholar]
  • 45.Maltezou HC, Constantopoulou I, Kallergi C, Vlahou V, Georgakopoulos D, Kafetzis DA, et al. Q fever in children in Greece. The American journal of tropical medicine and hygiene. 2004;70(5):540–4. [PubMed] [Google Scholar]
  • 46.Siksna I., Valciņa O., Ozoliņš G., Goldmanis M.: EFSA External Scientific Report: Latvian National Dietary Survey on the general population. EFSA supporting publication EN-1307, Luxembourg, 2017.

Decision Letter 0

Gianmarco Ferrara

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

4 Jan 2024

PONE-D-23-27370Molecular identification of Coxiella burnetii in raw milk samples collected from farm animals in districts Kasur and Lahore of Punjab, PakistanPLOS ONE

Dear Dr. Yasir Zahoor,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 03 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Gianmarco Ferrara, PhD, MVD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:

https://www.hindawi.com/journals/ijmicro/2021/6632036/

http://erepository.uonbi.ac.ke/bitstream/handle/11295/101328/Thesis%20final%20.pdf?isAllowed=y&sequence=1

https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0289944

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

3. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement.

4. We note that Figure 1 in your submission contain map image which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.  

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an ""Other"" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript describes the detection of Coxiella burnetii in milk samples collected from farms animals in districts Kasur and Lahore of Punjab, Pakistan. A PCR assay was performed. Unfortunately, too much information is lacking in the manuscript, particularly in Materials and Methods. My specific comments on the manuscript are shown in the attached file (highlighted in pink). Below are my other concerns:

1. For easier review, line numbers should be shown on the left side of each page. Also, please make sure to subject the manuscript to language review and editing.

2. In the introduction, please don't begin every sentence with C. burnetii, and the way punctuation marks are used confuse the reader

3. Tables in general, including the Supplementary ones are poorly organized and difficult to understand. I can't see the difference between table 1 and 2. And as a recomendation, when there are rows that add up to zero, it means that the sample size was insufficient, and that the analyzes carried out are not appropriate.

4. Phylogenetic analysis is insufficient. More isolates, both reported and those derived from their own study should be added.

5. The discussion is also poorly written. What was already mentioned in the summary, introduction and results is constantly repeated.

Reviewer #2: While the study addresses an important public health concern, there are several shortcomings and scientific mistakes that need attention.

Introduction:

The introduction is informative, but it lacks a clear statement of the research gap and a hypothesis. The authors could improve the introduction by providing more context on the global prevalence of C. burnetii in raw milk and its impact on public health. Furthermore, the reference citations in the introduction are somewhat outdated, and more recent literature should be incorporated to support the study's rationale.

Methodology:

The methodology section lacks details on the inclusion/exclusion criteria for farms and animals, potentially introducing selection bias. The use of a convenient sampling approach may not be representative of the overall population, and the authors should discuss the potential limitations associated with this sampling strategy. Additionally, the absence of information on the sensitivity and specificity of the PCR assay used raises concerns about the reliability of the results.

Discussion:

While the discussion compares the study findings with previous research, it fails to discuss the implications of the results for public health and the dairy industry in Punjab. Additionally, the discussion could benefit from a more critical analysis of the study limitations, such as the potential for contamination during sample collection and the use of a single gene target for detection.

Conclusion:

The conclusion provides a succinct summary, but it lacks specific recommendations for future research or practical implications for stakeholders. A more detailed discussion of the policy and public health implications of the study results would enhance the conclusion.

Overall, the manuscript should undergo thorough proofreading and editing for language and grammar issues. Additionally, the authors should consider updating references to include more recent publications in the field. Lastly, the manuscript would benefit from a more explicit statement on ethical considerations, especially regarding animal welfare and informed consent for sample collection.

Reviewer #3: General Comments:

The paper by Shujat et al. provided some interesting results of detection of Coxiella in milk samples of Pakistan. I understand this is the first study of its kind in Pakistan, and I think the results would be applicable to many other low-income countries with similar agriculture and dairy systems.

There were two aspects investigated: (1) molecular characterising and (2) prevalence estimation, investigating differences between species and geographic districts. The second part was a bit more restricted, in terms of sufficient number of animals across all species and district combinations, but nevertheless this is useful as a reference base for other future studies, and the authors provided a comprehensive analysis of the available data. One point that needs to be clarified is the overall objective due to a clash between the Introduction and Discussion. I think it really is both points above. In addition, some of the analyses need to be described in a bit more detail in the “Data Analysis” section to clarify some of the results being presented.

The following is a list of points I noted as I read through the manuscript. Most are minor editorial, but some may take some more time to work through. Please consider each point carefully, particularly the more substantial points, as this will result in a considerably improved manuscript.

Specific Comments:

Page 1: In the title page, I believe the affiliation for Wasim Shehzad should be ‘1’, not ‘2’.

Page 2, Abstract: (1) I think “convenience sampling” rather than “convenient”. (2) Also, be consistent in number of decimal places, suggest only one, so “7.4%” and “5.2%”. (3) Change “univariate” to “univariable” (The former indicates only one outcome variable. The latter indicates only one explanatory variable in the model). (4) Change “was differed” to “differed”.

�, Paragraph 3: Suggest “contaminated milk” rather than “contagious milk”.

Page 3, Paragraph 2: Change “Multicopy” to “multicopy”.

�, Paragraph 3: Change “about six” to “six” as that is what you have reported. However, please be more specific about “international databank”, e.g. a PubMed search? Make sure this list is current.

�, Paragraph 4: Change “convenient” to “convenience sampling”. Please provide a breakdown of the 304 samples by species.

�, Paragraph 5: Change “-20 °C temperature” to “-20 °C”.

Page 4, Paragraph 3: For the logistic regression, you need to mention the terms in the model, i.e. explanatory variable(s), not just the outcome variable. Also, where you used a chi-square analysis, is that what you labelled “univariate” (or “univariable” as mentioned above? Please clarify.

�, Paragraph 4: Perhaps write as “The University of Veterinary and Animal Sciences Advanced Studies and Research Board approved the study at its 50th meeting held on 8 February 2019” (suggesting explicit month name because of differing UK / US date format conventions – or was it “2 August 2019”?

Page 5, Figure 1: Change to “Lahore” in caption.

�, Paragraph 1: (1) As in Abstract, please round to 1 d.p., as sample sizes don’t lend to 2 d.p. accuracy. After “not statistically significant’, add P-value for the Kasur vs Lahore overall comparison (P = 0.63 I think). (2) Suggest change to “Coxiella burnetii prevalence in the four species of ruminants was”. (3) Suggest change to “although the differences between districts for each species were not statistically different (Table 2). I am not sure if the logistic regression model for looking at species × district interaction adds more, and it will be affected by the sample sizes, but will leave to authors if they decide to retain it. (4) Please add a bit more explanation about abortion as an outcome variable, I wasn’t sure how it was analysed giving an overall P-value of P = 0.03 (not described in Data Analysis section).

Page 6, Table 2: For the more detailed results in Table 2, comparing districts within each species, the Pearson chi-square procedure will fail due to small sample sizes. I would recommend using the Fisher exact test in that instance, the resultant P-values are cattle: 0.30, buffalo: 0.37, goat: 0.39, and sheep: 0.34. They don’t change much apart from goats.

Page 7, Figure 2: By “Labeled sequences”, do you mean the samples with the solid square symbol, i.e. your samples? Please clarify. Also, for publication, you may need higher quality image resolution than in this manuscript.

Page 9, Paragraph 1: Please clarify what the overall aim was: In the Introduction it was stated it was about prevalence estimation, but here it is about molecular characterisation. Also please avoid too much repetition of information already provided in the Introduction.

�, Paragraph 2: Suggest change “The previous study” to “A previous study”.

�, Paragraph 3: Suggest change “The distribution” to “The estimated prevalence”.

Page 10, Paragraph 1: The description of cattle and buffalo should be in a new paragraph, separate from your discussion of sheep. And then your overall recommendation in a final separate paragraph, which could be expanded with the specifics of recommendations.

References:

[2] Benenson & Tigertt: Missing volume number.

[13] Derrick: Missing page numbers.

[23] Tozer et al: Change to “Queensland”.

[26] Iqbal et al. This has now been published in Pak. J. Zool., please update reference.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Ruth Cabrera

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-23-27370_reviewer.pdf

pone.0301611.s005.pdf (788.9KB, pdf)
Attachment

Submitted filename: PONE review.docx

pone.0301611.s006.docx (12.2KB, docx)
PLoS One. 2024 Jun 6;19(6):e0301611. doi: 10.1371/journal.pone.0301611.r002

Author response to Decision Letter 0


4 Mar 2024

I would like to thank the reviewers very much for the detailed review of the manuscript. I appreciate the insights and believe the manuscript has been improved from their input. The suggestions are incorporated appropriately. The following are the responses to each of the reviewers’ comments:

Reviewer 1

1. For easier review, line numbers should be shown on the left side of each page. Also, please make sure to subject the manuscript to language review and editing.

Ans. Line number has been incorporated. The language of manuscript is reviewed and edited.

2. In the introduction, please don't begin every sentence with C. burnetii, and the way punctuation marks are used confuse the reader.

Ans. The sentences initiated by the word “C. burnetii” have been rephrased and the sentence is rephrased with edited punctuation marks as per suggestions (Line 46 – 57).

3. Tables in general, including the Supplementary ones are poorly organized and difficult to understand. I can't see the difference between table 1 and 2. And as a recommendation, when there are rows that add up to zero, it means that the sample size was insufficient, and that analyzes carried out are not appropriate.

4. Ans. In supplementary tables, the table 1 refers to the statistical difference between exotic and indigenous breed while table 2 refers to the statistical difference between exotic and indigenous breed among the studied individual species i.e. cattle, buffalo, goat and sheep. As the Pearson’s chi square test is not accurate for small sample size, Table 2 is re- analyzed using Fisher s’ exact test. All the supplementary tables are re- analyzed using Fisher s’ exact test (Table S2, S3 and S4 were re-analyzed using Fishers exact test, Please review the supplementary tables file).

5. Phylogenetic analysis is insufficient. More isolates, both reported and those derived from their own study should be added.

Ans. More isolates are incorporated in the phylogenetic analysis. One additional query sequence from Lahore and reported sequences from two cities of Turkey and Tamil Nadu city of India

(Fig. 2).

6. The discussion is also poorly written. What was already mentioned in the summary, introduction and results is constantly repeated.

Ans. The discussion is rephrased in the edited manuscript. The repeated lines are deleted in the edited manuscript. The information regarding Coxiella burnetii routes of transmission in humans are discussed in the discussion section of the edited manuscript.

Reviewer 2

1. The introduction is informative, but it lacks a clear statement of the research gap and a hypothesis. The authors could improve the introduction by providing more context on the global prevalence of C. burnetii in raw milk and its impact on public health. Furthermore, the reference citations in the introduction are somewhat outdated, and more recent literature should be incorporated to support the study's rationale.

Ans. The research gap and hypothesis statement is incorporated in the edited manuscript (Line 97 -101). The information regarding worldwide prevalence of Coxiella burnetii in raw milk and its implications on public health is concerned in the introduction section of the edited manuscript with incorporated recent references (Line 69 -89).

2. The methodology section lacks details on the inclusion/exclusion criteria for farms and animals, potentially introducing selection bias. The use of a convenient sampling approach may not be representative of the overall population, and the authors should discuss the potential limitations associated with this sampling strategy. Additionally, the absence of information on the sensitivity and specificity of the PCR assay used raises concerns about the reliability of the results.

Ans. The inclusion and exclusion criteria for farms and animals to collect the raw milk samples have been defined in the methodology section with implementing sampling strategy limitations (Line 112 -115). The sensitivity and specificity of the used PCR assay has been discussed in the edited manuscript (Line 138- 141).

3. While the discussion compares the study findings with previous research, it fails to discuss the implications of the results for public health and the dairy industry in Punjab. Additionally, the discussion could benefit from a more critical analysis of the study limitations, such as the potential for contamination during sample collection and the use of a single gene target for detection.

Ans. The implications of Coxiella burnetii infection on public health and dairy industry are concerned in the discussion section of the edited manuscript (Line 278 -281). The limitations regarding gene targets have been discussed in the discussion section (Line 286 – 295).

4. The conclusion provides a succinct summary, but it lacks specific recommendations for future research or practical implications for stakeholders. A more detailed discussion of the policy and public health implications of the study results would enhance the conclusion.

Ans. Recommendations for future concerns for stakeholders and policies for public health concerns have been suggested in the conclusion section of the edited manuscript

(Line 303 – 309).

5. Additionally, the authors should consider updating references to include more recent publications in the field. Lastly, the manuscript would benefit from a more explicit statement on ethical considerations, especially regarding animal welfare and informed consent for sample collection.

Ans. The manuscript has been proofread for language review. The updated reports have been cited in the introduction and discussion section of the edited manuscript. Ethical statement regarding animal rights and consent has been incorporated in the methodology section of the manuscript (Line 162 – 167).

Reviewer 3

1. There were two aspects investigated: (1) molecular characterising and (2) prevalence estimation, investigating differences between species and geographic districts. The second part was a bit more restricted, in terms of sufficient number of animals across all species and district combinations, but nevertheless this is useful as a reference base for other future studies, and the authors provided a comprehensive analysis of the available data.

Ans. It is the first evidence study for Coxiella burnetii detection in raw milk samples in Pakistan. In the past studies the Coxiella burnetii was detected in blood, meat and serum samples of livestock animals. There are no studies available on milk samples so far. The present study estimated the Coxiella burnetii prevalence in raw milk samples collected from two districts of Punjab, Pakistan. Future studies will analyze its diagnosis by targeting animals on large scale and other geographic districts of Punjab, Pakistan.

2. One point that needs to be clarified is the overall objective due to a clash between the Introduction and Discussion. I think it really is both points above. In addition, some of the analyses need to be described in a bit more detail in the “Data Analysis” section to clarify some of the results being presented.

Ans. The objective is clarified in the discussion section. The explanatory variables are mentioned in the data analysis section (Line 157-160).

The following is a list of points I noted as I read through the manuscript. Most are minor editorial, but some may take some more time to work through. Please consider each point carefully, particularly the more substantial points, as this will result in a considerably improved manuscript.

3. Page 1: In the title page, I believe the affiliation for Wasim Shehzad should be ‘1’, not ‘2’.

Ans. The affiliation has been replaced to 1 in the title page of the edited manuscript

(Line 4).

4. Page 2, Abstract: (1) I think “convenience sampling” rather than “convenient”. (2) Also, be consistent in number of decimal places; suggest only one, so “7.4%” and “5.2%”. (3) Change “univariate” to “univariable” (The former indicates only one outcome variable. The latter indicates only one explanatory variable in the model). (4) Change “was differed”to“differed”.

Ans. The word “convenience sampling” is replaced with convenient sampling in the edited manuscript (Line 23). The one decimal point is followed in the manuscript (Line 27). The word “univariate” is replaced by “univariable” (Line 29).

5. Paragraph 3: Suggest “contaminated milk” rather than “contagious milk”.

Ans. The contagious milk is replaced by contaminated milk as per suggestion (Line 53).

6. Page 3, Paragraph 2: Change “Multicopy” to “multicopy”.

Ans. The word “Multicopy” is replaced by “multicopy” (Line 66).

7. Paragraph 3: Change “about six” to “six” as that is what you have reported. However, please be more specific about “international databank”, e.g. a PubMed search? Make sure this list is current.

Ans. The word “about six” is replaced by “six”(Line 96). The databank is specified in the edited manuscript (Line 97).

8. Paragraph 4: Change “convenient” to “convenience sampling”. Please provide a breakdown of the 304 samples by species.

Ans. The word “convenient” is replaced by “convenience sampling” (Line 106). Individual species sub division is incorporated in the manuscript (Line 107 & 108).

9. Paragraph 5: Change “-20 °C temperature” to “-20 °C”.

Ans. The word “-20 °C temperature” is replaced by “-20 °C” (Line 126).

10. Page 4, Paragraph 3: For the logistic regression, you need to mention the terms in the model, i.e. explanatory variable(s), not just the outcome variable. Also, where you used a chi-square analysis, is that what you labelled “univariate” (or “univariable” as mentioned above?Pleaseclarify.

Ans. The explanatory variables are incorporated in the edited manuscript (Line 159 & 160). The fisher test function is used in the revised version (Line 157).

11. Paragraph 4: Perhaps write as “The University of Veterinary and Animal Sciences Advanced Studies and Research Board approved the study at its 50th meeting held on 8 February 2019” (suggesting explicit month name because of differing UK / US date format conventions – or was it “2 August 2019”?

Page 5, Figure 1: Change to “Lahore” in caption.

Ans. The date is formatted as “8 February 2019” in the edited manuscript as per suggestions (Line 164). The word “Lahure” is replaced by “Lahore” in the Figure 1 label (Line 172).

12. Paragraph 1: (1) As in Abstract, please round to 1 d.p., as sample sizes don’t lend to 2 d.p. accuracy. After “not statistically significant’, add P-value for the Kasur vs Lahore overall comparison (P = 0.63 I think). (2) Suggest change to “Coxiella burnetii prevalence in the four species of ruminants was”. (3) Suggest change to “although the differences between districts for each species were not statistically different (Table 2). I am not sure if the logistic model for looking at species × district interaction adds more, and it will be affected by the sample sizes, but will leave to authors if they decide to retain it. (4) Please add a bit more explanation about abortion as an outcome variable, I wasn’t sure how it was analysed giving an overall P-value of P = 0.03 (not described in Data Analysis section).

Ans. I) 1 decimal point is followed in the edited manuscript (Line 177). II) P value is incorporated in the edited manuscript (Line 178). III) The phrase “although the difference was not statistically different” is rephrased as Coxiella burnetii prevalence in the four species of ruminants was” in the edited manuscript (Line 178).

13. Page 6, Table 2: For the more detailed results in Table 2, comparing districts within each species, the Pearson chi-square procedure will fail due to small sample sizes. I would recommend using the Fisher exact test in that instance, the resultant P-values are cattle: 0.30, buffalo: 0.37, goat: 0.39, and sheep: 0.34. They don’t change much apart from goats.

Ans. Fisher exact test is applied in Table 2. The values were same as mentioned above i.e. cattle: 0.30, buffalo: 0.37, goat: 0.39, and sheep: 0.34. The values are incorporated in the edited manuscript (Line 202 - 203).

14. Page 7, Figure 2: By “Labeled sequences”, do you mean the samples with the solid square symbol, i.e. your samples? Please clarify. Also, for publication, you may need higher quality image resolution than in this manuscript.

Page 9, Paragraph 1: Please clarify what the overall aim was: In the Introduction it was stated it was about prevalence estimation, but here it is about molecular characterisation. Also please avoid too much repetition of information already provided in the Introduction.

Ans. The samples with squared symbols were query sequences. Discussion and introduction sections are updated. The discussion section is rephrased to avoid repetition in the edited manuscript.

15. Paragraph 2: Suggest change “The previous study” to “A previous study”. Paragraph 3: Suggest change “The distribution” to “The estimated prevalence”.

Ans. The word “The previous study” is replaced to “A previous study” (Line 251). The word “The distribution” is replaced to “The estimated prevalence” in the edited manuscript (Line 258).

16. Page 10, Paragraph 1: The description of cattle and buffalo should be in a new paragraph, separate from your discussion of sheep. And then your overall recommendation in a final separate paragraph, which could be expanded with the specifics of recommendations.

References:

[2] Benenson & Tigertt: Missing volume number.

[13] Derrick: Missing page numbers.

[31] Tozer et al: Change to “Queensland”.

[35] Iqbal et al. This has now been published in Pak. J. Zool., please update reference.

Ans. The references are updated in the edited manuscript as per suggestion.

Attachment

Submitted filename: Response to reviewers.docx

pone.0301611.s007.docx (34.1KB, docx)

Decision Letter 1

Gianmarco Ferrara

19 Mar 2024

Molecular identification of Coxiella burnetii in raw milk samples collected from farm animals in districts Kasur and Lahore of Punjab, Pakistan

PONE-D-23-27370R1

Dear Dr. Muhammad Yasir Zahoor,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at http://www.editorialmanager.com/pone/ and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Gianmarco Ferrara, PhD, MVD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #3: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: After review, I consider the article suitable for publication. However, as a last comment, the figures still do not have the necessary resolution, and are difficult to view.

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: No

**********

Acceptance letter

Gianmarco Ferrara

26 Apr 2024

PONE-D-23-27370R1

PLOS ONE

Dear Dr. Zahoor,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Gianmarco Ferrara

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Supplementary tables.

    (PDF)

    pone.0301611.s001.pdf (198.1KB, pdf)
    S2 File

    (MAS)

    pone.0301611.s002.mas (118.6KB, mas)
    S3 File

    (SAS7BDAT)

    pone.0301611.s003.sas7bdat (128KB, sas7bdat)
    S4 File

    (TXT)

    pone.0301611.s004.txt (13.8KB, txt)
    Attachment

    Submitted filename: PONE-D-23-27370_reviewer.pdf

    pone.0301611.s005.pdf (788.9KB, pdf)
    Attachment

    Submitted filename: PONE review.docx

    pone.0301611.s006.docx (12.2KB, docx)
    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0301611.s007.docx (34.1KB, docx)

    Data Availability Statement

    All relevant data for this study are publicly available from the OSF repository (https://osf.io/hzd9c).


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES